Ovarian Cancer Patient Questionnaire on Genetic Testing
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00486707|
Recruitment Status : Completed
First Posted : June 15, 2007
Last Update Posted : August 1, 2012
|Condition or disease||Intervention/treatment|
|Ovarian Cancer||Behavioral: Questionnaire|
All eligible patients being seen in the Gynecology Center at the M.D. Anderson Cancer Center and at Gynecologic Oncology of Houston for follow-up or a new diagnosis of ovarian cancer will be asked to participate in this study by completing a questionnaire.
This study will end when 400 completed questionnaires have been collected. We estimate that 40-60 ovarian cancer patients are seen in the Gynecology Center at the M.D. Anderson Cancer Center each week and that 20- 40 ovarian cancer patients are seen at Gynecologic Oncology of Houston each week. The completion of 400 questionnaires will provide adequate data to address our question in an expeditious time frame. The initial phase of this study is exploratory and does not involve a comparison group.
|Study Type :||Observational|
|Actual Enrollment :||237 participants|
|Official Title:||Questionnaire for Ovarian Cancer Patients Regarding Acceptance and Willingness to Undergo Genetic Testing|
|Study Start Date :||June 2007|
|Primary Completion Date :||October 2008|
|Study Completion Date :||October 2008|
|Patients with ovarian cancer||
A questionnaire will be completed.
Other Name: Survey
- Participants' Response to Survey Questions (Yes/No) [ Time Frame: 15-20 minutes to complete survey ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00486707
|United States, Texas|
|U.T.M.D. Anderson Cancer Center|
|Houston, Texas, United States, 77030|
|Principal Investigator:||Karen H. Lu, MD||M.D. Anderson Cancer Center|